JNJ Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | HEWSON MARILLYN A | director | 6,430.925 | A-Award | A | 233.63 | 155.16 | 36,250.03 |
| 2023-03-07 | Washington A. Eugene | director | 28,569.4483 | A-Award | A | 201.405 | 155.16 | 31,250.00 |
| 2023-03-06 | Swanson James D. | officer: | 9,215.3198 | S-Sale | D | 1,061.6801 | 154.66 | 164,199.44 |
| 2023-02-13 | Decker Robert J | officer: VP Corporate Controller | 937 | A-Award | A | 937 | 0.00 | 0.00 |
| 2023-02-13 | Decker Robert J | officer: VP Corporate Controller | 7,756 | A-Award | A | 7,756 | 162.75 | 1,262,289.00 |
| 2023-02-13 | Decker Robert J | officer: VP Corporate Controller | 16,917 | F-InKind | D | 397 | 162.01 | 64,317.97 |
| 2023-02-13 | Decker Robert J | officer: VP Corporate Controller | 17,314 | A-Award | A | 1,451 | 0.00 | 0.00 |
| 2023-02-13 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 10,409 | A-Award | A | 10,409 | 0.00 | 0.00 |
| 2023-02-13 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 172,250 | A-Award | A | 172,250 | 162.75 | 28,033,687.50 |
| 2023-02-13 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 316,393 | F-InKind | D | 13,599 | 162.01 | 2,203,173.99 |
| 2023-02-13 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 329,992 | A-Award | A | 31,319 | 0.00 | 0.00 |
| 2023-02-13 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 2,773 | A-Award | A | 2,773 | 0.00 | 0.00 |
| 2023-02-13 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 45,890 | A-Award | A | 45,890 | 162.75 | 7,468,597.50 |
| 2023-02-13 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 122,696.0055 | F-InKind | D | 5,765 | 162.01 | 933,987.65 |
| 2023-02-13 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 128,461.0055 | A-Award | A | 12,468 | 0.00 | 0.00 |
| 2023-02-13 | Hait William | officer: | 2,500 | A-Award | A | 2,500 | 0.00 | 0.00 |
| 2023-02-13 | Hait William | officer: | 41,366 | A-Award | A | 41,366 | 162.75 | 6,732,316.50 |
| 2023-02-13 | Hait William | officer: | 87,747 | F-InKind | D | 4,586 | 162.01 | 742,977.86 |
| 2023-02-13 | Hait William | officer: | 92,333 | A-Award | A | 9,640 | 0.00 | 0.00 |
| 2023-02-13 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 3,704 | A-Award | A | 3,704 | 0.00 | 0.00 |
| 2023-02-13 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 61,295 | A-Award | A | 61,295 | 162.75 | 9,975,761.25 |
| 2023-02-13 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 54,824.9545 | F-InKind | D | 7,158 | 162.01 | 1,159,667.58 |
| 2023-02-13 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 61,982.9545 | A-Award | A | 17,994 | 0.00 | 0.00 |
| 2023-02-13 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 3,417 | A-Award | A | 3,417 | 0.00 | 0.00 |
| 2023-02-13 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 56,555 | A-Award | A | 56,555 | 162.75 | 9,204,326.25 |
| 2023-02-13 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 65,915.2661 | F-InKind | D | 6,430 | 162.01 | 1,041,724.30 |
| 2023-02-13 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 72,345.2661 | A-Award | A | 13,710 | 0.00 | 0.00 |
| 2023-02-13 | Swanson James D. | officer: | 1,341 | A-Award | A | 1,341 | 0.00 | 0.00 |
| 2023-02-13 | Swanson James D. | officer: | 22,191 | A-Award | A | 22,191 | 162.75 | 3,611,585.25 |
| 2023-02-13 | Swanson James D. | officer: | 10,277 | F-InKind | D | 918 | 162.01 | 148,725.18 |
| 2023-02-13 | Swanson James D. | officer: | 11,195 | A-Award | A | 3,228 | 0.00 | 0.00 |
| 2023-02-13 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 3,906 | A-Award | A | 3,906 | 0.00 | 0.00 |
| 2023-02-13 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 64,634 | A-Award | A | 64,634 | 162.75 | 10,519,183.50 |
| 2023-02-13 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 139,590.001 | F-InKind | D | 10,569 | 162.01 | 1,712,283.69 |
| 2023-02-13 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 150,159.001 | A-Award | A | 21,422 | 0.00 | 0.00 |
| 2023-02-13 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 1,953 | A-Award | A | 1,953 | 0.00 | 0.00 |
| 2023-02-13 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 32,317 | A-Award | A | 32,317 | 162.75 | 5,259,591.75 |
| 2023-02-13 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 78,398.8735 | F-InKind | D | 4,891 | 162.01 | 792,390.91 |
| 2023-02-13 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 83,289.8735 | A-Award | A | 10,839 | 0.00 | 0.00 |
| 2023-02-13 | Wolk Joseph J | officer: Exec VP, CFO | 5,338 | A-Award | A | 5,338 | 0.00 | 0.00 |
| 2023-02-13 | Wolk Joseph J | officer: Exec VP, CFO | 88,334 | A-Award | A | 88,334 | 162.75 | 14,376,358.50 |
| 2023-02-13 | Wolk Joseph J | officer: Exec VP, CFO | 50,397.204 | F-InKind | D | 8,578 | 162.01 | 1,389,721.78 |
| 2023-02-13 | Wolk Joseph J | officer: Exec VP, CFO | 58,975.204 | A-Award | A | 20,693 | 0.00 | 0.00 |
| 2023-02-10 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 0 | M-Exempt | D | 2,999 | 0.00 | 0.00 |
| 2023-02-10 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 43,988.9545 | F-InKind | D | 823 | 162.08 | 133,391.84 |
| 2023-02-10 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 44,811.9545 | M-Exempt | A | 2,999 | 0.00 | 0.00 |
| 2023-02-10 | Swanson James D. | officer: | 0 | M-Exempt | D | 1,291 | 0.00 | 0.00 |
| 2023-02-10 | Swanson James D. | officer: | 7,967 | F-InKind | D | 388 | 162.08 | 62,887.04 |
| 2023-02-10 | Swanson James D. | officer: | 8,355 | M-Exempt | A | 1,291 | 0.00 | 0.00 |
| 2023-02-10 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 0 | M-Exempt | D | 2,078 | 0.00 | 0.00 |
| 2023-02-10 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 115,993.0055 | F-InKind | D | 761 | 162.08 | 123,342.88 |
| 2023-02-10 | Fasolo Peter | officer: Exec VP, Chief HR Officer | 116,754.0055 | M-Exempt | A | 2,078 | 0.00 | 0.00 |
| 2023-02-10 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | 0 | M-Exempt | D | 1,592 | 0.00 | 0.00 |
| 2023-02-10 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | 16,662 | F-InKind | D | 597 | 162.08 | 96,761.76 |
| 2023-02-10 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | 17,259 | M-Exempt | A | 1,592 | 0.00 | 0.00 |
| 2023-02-10 | Decker Robert J | officer: VP Corporate Controller | 0 | M-Exempt | D | 581 | 0.00 | 0.00 |
| 2023-02-10 | Decker Robert J | officer: VP Corporate Controller | 15,863 | F-InKind | D | 191 | 162.08 | 30,957.28 |
| 2023-02-10 | Decker Robert J | officer: VP Corporate Controller | 16,054 | M-Exempt | A | 581 | 0.00 | 0.00 |
| 2023-02-10 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 0 | M-Exempt | D | 2,285 | 0.00 | 0.00 |
| 2023-02-10 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 58,635.2661 | F-InKind | D | 826 | 162.08 | 133,878.08 |
| 2023-02-10 | Mongon Thibaut | officer: Exec VP, WW Chair, Cons Health | 59,461.2661 | M-Exempt | A | 2,285 | 0.00 | 0.00 |
| 2023-02-10 | Hait William | officer: | 0 | M-Exempt | D | 3,856 | 0.00 | 0.00 |
| 2023-02-10 | Hait William | officer: | 82,693 | F-InKind | D | 1,399 | 162.08 | 226,749.92 |
| 2023-02-10 | Hait William | officer: | 84,092 | M-Exempt | A | 3,856 | 0.00 | 0.00 |
| 2023-02-10 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 0 | M-Exempt | D | 3,570 | 0.00 | 0.00 |
| 2023-02-10 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 128,737.001 | F-InKind | D | 1,289 | 162.08 | 208,921.12 |
| 2023-02-10 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 130,026.001 | M-Exempt | A | 3,570 | 0.00 | 0.00 |
| 2023-02-10 | Wolk Joseph J | officer: Exec VP, CFO | 0 | M-Exempt | D | 3,449 | 0.00 | 0.00 |
| 2023-02-10 | Wolk Joseph J | officer: Exec VP, CFO | 38,282.204 | F-InKind | D | 979 | 162.08 | 158,676.32 |
| 2023-02-10 | Wolk Joseph J | officer: Exec VP, CFO | 39,261.204 | M-Exempt | A | 3,449 | 0.00 | 0.00 |
| 2023-02-10 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 0 | M-Exempt | D | 1,807 | 0.00 | 0.00 |
| 2023-02-10 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 72,450.8735 | F-InKind | D | 667 | 162.08 | 108,107.36 |
| 2023-02-10 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | 73,117.8735 | M-Exempt | A | 1,807 | 0.00 | 0.00 |
| 2023-02-10 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 0 | M-Exempt | D | 5,220 | 0.00 | 0.00 |
| 2023-02-10 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 298,673 | F-InKind | D | 2,267 | 162.08 | 367,435.36 |
| 2023-02-10 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 300,940 | M-Exempt | A | 5,220 | 0.00 | 0.00 |
| 2023-01-17 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 0 | M-Exempt | D | 148,538 | 72.54 | 10,774,946.52 |
| 2023-01-17 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 295,720 | F-InKind | D | 98,795 | 173.43 | 17,134,016.85 |
| 2023-01-17 | Duato Joaquin | director, officer: CEO and Chairman of the Board | 394,515 | M-Exempt | A | 148,538 | 72.54 | 10,774,946.52 |
| 2023-01-17 | Gorsky Alex | director | 0 | M-Exempt | D | 547,692 | 72.54 | 39,729,577.68 |
| 2023-01-17 | Gorsky Alex | director | 766,583.671 | F-InKind | D | 366,610 | 173.43 | 63,581,172.30 |
| 2023-01-17 | Gorsky Alex | director | 1,133,193.671 | M-Exempt | A | 547,692 | 72.54 | 39,729,577.68 |
| 2022-12-13 | Wolk Joseph J | officer: Exec VP, CFO | 0 | M-Exempt | D | 12,926 | 90.44 | 1,169,027.44 |
| 2022-12-13 | Wolk Joseph J | officer: Exec VP, CFO | 35,812.204 | S-Sale | D | 12,926 | 179.62 | 2,321,755.19 |
| 2022-12-13 | Wolk Joseph J | officer: Exec VP, CFO | 48,738.204 | S-Sale | D | 1,855 | 179.46 | 332,905.72 |
| 2022-12-13 | Wolk Joseph J | officer: Exec VP, CFO | 50,593.204 | M-Exempt | A | 1,855 | 72.54 | 134,561.70 |
| 2022-12-13 | Wolk Joseph J | officer: Exec VP, CFO | 48,738.204 | M-Exempt | A | 12,926 | 90.44 | 1,169,027.44 |
| 2022-12-06 | HEWSON MARILLYN A | director | 6,152.487 | A-Award | A | 240.466 | 178.70 | 42,971.27 |
| 2022-12-06 | Washington A. Eugene | director | 28,162.9373 | A-Award | A | 350.743 | 178.70 | 62,677.77 |
| 2022-12-06 | WEINBERGER MARK A | director | 6,276.051 | A-Award | A | 241.016 | 178.70 | 43,069.56 |
| 2022-11-30 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 0 | M-Exempt | D | 73,323 | 72.54 | 5,318,850.42 |
| 2022-11-30 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 41,812.9545 | S-Sale | D | 71,923 | 175.46 | 12,619,271.54 |
| 2022-11-30 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 113,735.9545 | S-Sale | D | 1,400 | 176.09 | 246,529.22 |
| 2022-11-30 | McEvoy Ashley | officer: EVP, WW Chair, MedTech | 115,135.9545 | M-Exempt | A | 73,323 | 72.54 | 5,318,850.42 |
| 2022-11-22 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 0 | M-Exempt | D | 76,923 | 72.54 | 5,579,994.42 |
| 2022-11-22 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 126,456.001 | S-Sale | D | 76,923 | 176.78 | 13,598,401.79 |
| 2022-11-22 | Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | 203,379.001 | M-Exempt | A | 76,923 | 72.54 | 5,579,994.42 |
| 2022-11-18 | Decker Robert J | officer: Controller, CAO | 0 | M-Exempt | D | 16,928 | 90.44 | 1,530,968.32 |
| 2022-11-18 | Decker Robert J | officer: Controller, CAO | 15,473 | S-Sale | D | 16,928 | 175.00 | 2,962,400.00 |
| 2022-11-18 | Decker Robert J | officer: Controller, CAO | 32,401 | M-Exempt | A | 16,928 | 90.44 | 1,530,968.32 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.